1. Home
  2. BLFS vs KMTS Comparison

BLFS vs KMTS Comparison

Compare BLFS & KMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • KMTS
  • Stock Information
  • Founded
  • BLFS 1987
  • KMTS 2014
  • Country
  • BLFS United States
  • KMTS United States
  • Employees
  • BLFS N/A
  • KMTS N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • KMTS
  • Sector
  • BLFS Health Care
  • KMTS
  • Exchange
  • BLFS Nasdaq
  • KMTS NYSE
  • Market Cap
  • BLFS 1.0B
  • KMTS 1.0B
  • IPO Year
  • BLFS 1989
  • KMTS 2025
  • Fundamental
  • Price
  • BLFS $22.10
  • KMTS $16.50
  • Analyst Decision
  • BLFS Strong Buy
  • KMTS Buy
  • Analyst Count
  • BLFS 7
  • KMTS 5
  • Target Price
  • BLFS $30.57
  • KMTS $26.80
  • AVG Volume (30 Days)
  • BLFS 479.2K
  • KMTS 445.9K
  • Earning Date
  • BLFS 08-07-2025
  • KMTS 07-15-2025
  • Dividend Yield
  • BLFS N/A
  • KMTS N/A
  • EPS Growth
  • BLFS N/A
  • KMTS N/A
  • EPS
  • BLFS N/A
  • KMTS N/A
  • Revenue
  • BLFS $87,762,000.00
  • KMTS $59,815,000.00
  • Revenue This Year
  • BLFS $21.21
  • KMTS $41.49
  • Revenue Next Year
  • BLFS $17.58
  • KMTS $52.96
  • P/E Ratio
  • BLFS N/A
  • KMTS N/A
  • Revenue Growth
  • BLFS 34.80
  • KMTS 115.05
  • 52 Week Low
  • BLFS $19.10
  • KMTS $13.25
  • 52 Week High
  • BLFS $29.55
  • KMTS $26.15
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 51.26
  • KMTS N/A
  • Support Level
  • BLFS $21.94
  • KMTS N/A
  • Resistance Level
  • BLFS $22.78
  • KMTS N/A
  • Average True Range (ATR)
  • BLFS 0.89
  • KMTS 0.00
  • MACD
  • BLFS 0.11
  • KMTS 0.00
  • Stochastic Oscillator
  • BLFS 58.63
  • KMTS 0.00

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About KMTS KESTRA MEDICAL TECHNOLOGIES LTD

Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.

Share on Social Networks: